GENEREX BIOTECHNOLOGY RECEIVES GRANT OF CANADIAN PATENT

Generex Biotechnology Corporation (Nasdaq: GNBT -- News), a leader in the area of buccal drug delivery, today announced that it has been granted a patent by the Canadian Intellectual Property Office titled "Mixed Micellar Delivery System and Method of Preparation." This patent, an extant United States Patent registered by the Company, relates to an improved delivery system for the administration of large-molecule pharmaceuticals, particularly through the oral and nasal membranes.

Yahoo News (http://biz.yahoo.com/prnews/050909/nyf038.html?.v=17)